Gyre Therapeutics
GYRE
GYRE
89 hedge funds and large institutions have $113M invested in Gyre Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 80 → 89 (+9)
0.91% more ownership
Funds ownership: 8.63% → 9.54% (+0.91%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
89
Holding in Top 10
2
Calls
$2.92M
Puts
$577K
Top Buyers
| 1 | +$10.7M | |
| 2 | +$8.14M | |
| 3 | +$5.55M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$5.04M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.51M |
Top Sellers
| 1 | -$2.66M | |
| 2 | -$2.11M | |
| 3 | -$1.13M | |
| 4 |
Renaissance Technologies
New York
|
-$918K |
| 5 |
Millennium Management
New York
|
-$729K |